NLRP3 and metabolic dysfunction-associated steatohepatitis: Molecular docking experiments have demonstrated that nicotinic acid interacts with TLR4, inhibiting the assembly of the NLRP3-ASC-Caspase-1 complex, suppressing pyroptosis, and alleviating NASH [164].